N. Johnson

发表

Adjuvant radiotherapy for stage I endometrial cancer.

H. Kitchener, T. Lawrie, A. Kong, 2012, The Cochrane database of systematic reviews.

Adjuvant chemotherapy for endometrial cancer after hysterectomy.

A. Bryant, P. Cornes, N. Johnson, 2011, The Cochrane database of systematic reviews.

Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta‐analysis

P. Cornes, N. Johnson, 2007, BJOG : an international journal of obstetrics and gynaecology.

Delays in treating endometrial cancer in the South West of England

J. Murdoch, K. Waring, N. Das, 2011, British Journal of Cancer.

Adjuvant radiotherapy for stage I endometrial cancer.

H. Kitchener, T. Lawrie, A. Kong, 2012, The Cochrane database of systematic reviews.

Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.

H. Kitchener, T. Lawrie, A. Kong, 2012, Journal of the National Cancer Institute.

Vaginal dilator therapy for women receiving pelvic radiotherapy.

N. Johnson, T. Miles, 2010, The Cochrane database of systematic reviews.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

N. Johnson, K. Jaaback, 2006, The Cochrane database of systematic reviews.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

T. Lawrie, N. Johnson, K. Jaaback, 2011, The Cochrane database of systematic reviews.

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.

M. Parmar, M. Parmar, G. Jayson, 2018, The Lancet. Oncology.

Pain scores during surgical drains removal after obstetrics and gynaecological surgery

C. Phillips, I. Mahfouz, N. Johnson, 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Randomised trial showing that lidocaine should be ‘squirted’ through a peritoneal drain before it is removed

N. Johnson, C. Jess, A. Makins, 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

EORTC-GcG/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA)

G. Kenter, I. Vergote, F. Amant, 2008 .

Vaginal dilator therapy for women receiving pelvic radiotherapy.

N. Johnson, T. Miles, 2014, The Cochrane database of systematic reviews.

A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools

Geoffrey Lee, N. Smoll, K. Drummond, 2015, Journal of Clinical Neuroscience.

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

G. Kenter, I. Vergote, F. Amant, 2010, The New England journal of medicine.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

N. Johnson, Theresa A Lawrie, K. Jaaback, 2016, The Cochrane database of systematic reviews.

BGCS uterine cancer guidelines: Recommendations for practice.

A. Walther, C. Fotopoulou, P. Martin-Hirsch, 2017, European journal of obstetrics, gynecology, and reproductive biology.

Adjuvant radiotherapy for stage I endometrial cancer.

I. Simera, P. Cornes, H. Kitchener, 2007, The Cochrane database of systematic reviews.

Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature

P. Cornes, N. Johnson, TP Miles, 2010, BJOG : an international journal of obstetrics and gynaecology.

Uterine Cancer Guidelines : Recommendations for Practice

J. Ledermann, S. Leeson, T. Mould, 2017 .

Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.

J. Seoane, I. Vergote, R. Verheijen, 2011, European journal of cancer.

Author response to: Systematic review and meta‐analysis on adjuvant radiotherapy for early endometrial cancer

P. Cornes, N. Johnson, 2008 .

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

E. Berns, D. Lambrechts, F. Amant, 2014, International Journal of Gynecologic Cancer.

Are there common triggers of preterm deliveries?

N. Johnson, 2002, BJOG : an international journal of obstetrics and gynaecology.

Simplifying laparoscopic surgery for ectopic pregnancies

N. Johnson, 1993, British Journal of Obstetrics and Gynaecology.

Bleeding, discharge, pain and dysmenorrhoea after large loop excision of the transformation zone (LLETZ)

N. Johnson, C. Jess, Joelle Williams, 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Predicting residual disease after excision of cervical dysplasia.

L. Hirschowitz, N. Johnson, R. Porter, 2004, BJOG: an International Journal of Obstetrics and Gynaecology.

Predicting residual disease after excision of cervical dysplasia

L. Hirschowitz, N. Johnson, R. Porter, 2003 .

Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancer

P. Cornes, N. Johnson, T. Miles, 2015 .

How long does it take to perform an operative vaginal delivery?

N. Johnson, Alexandra Eldridge, 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Two large randomised trials show ovarian cancer screening has minimal impact on survival

N. Johnson, 2018, BJOG : an international journal of obstetrics and gynaecology.

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.

G. Kenter, M. Nankivell, S. Kehoe, 2018, The Lancet. Oncology.